VAERS 2718771
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GU9694
- Staat
- CO
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 29.11.2023
- Impfdatum
- 13.09.2022
- Beginn
- 06.08.2021
- Tage bis Beginn
- -
- Dosis
- 6
- Route/Site
- - / RA
Symptomtext
Treatment of COVID-19; Treatment of COVID-19; vaccine brand other=Moderna; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 67-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Sep2022 as dose 6 (booster), single (Lot number: GU9694) at the age of 65 years, in right arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 06Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 27Jan2021 as dose 1, single (Lot number: SA5MC), in left arm, on 26Feb2021 as dose 2, single (Lot number: O4MZ0A), in left arm, on 17Dec2021 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm, on 17Apr2022 as dose 5 (booster), single (Batch/Lot number: unknown), in left arm, on 24Apr2023 as dose 7 (booster), single (Batch/Lot number: unknown), in left arm and on 24Sep2023 as dose 8 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 06Aug2021, outcome "unknown", described as "vaccine brand other=Moderna"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Nov2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Nov2023) positive, notes: positive test results. Therapeutic measures were taken as a result of drug ineffective, covid-19 as Paxlovid from 10Nov2023 to 15Nov2023. Patient had no known allergies. The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300384617 same patient, different product/event;
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Date: 202311; Test Name: COVID-19 test; Test Result: Positive ; Comments: positive test results
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Asthma
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -